Methods for isolating crystalline form I of 5-azacytidine
US7700770B2 · kind B2 · utility
18Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2005 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Aug 18, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention includes methods for isolating crystalline Form I of 5-azacytidine substantially free of other forms, wherein 5-azacytidine is represented by the formula:The invention also includes pharmaceutical compositions comprising Form I of 5-azacytidine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.